Peptide Referee

Vilon: research, legal status and who sells it

This page is information, not medical advice. Vilon is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.

Also known as
Lys-Glu, KE peptide
Category
Synthetic dipeptide (Khavinson peptide bioregulator)
Evidence level
Preclinical (lab and animal studies)
Price range
$2.15/mg to $4.00/mg, median $2.72/mg across 9 vendors (compare)
Our lab tests
None yet (how testing will work)
WhereStatus
United StatesNo FDA-approved drug contains vilon [1].
United KingdomNo UK-licensed medicine containing vilon appears in the MHRA products database [2].
European UnionNo medicine containing vilon is authorized in the EU, according to EMA's central and Article 57 product data [3][4].
CanadaNo product containing vilon appears in Health Canada's Drug Product Database [5].
AustraliaVilon is not named in Australia's Poisons Standard (October 2026) [6].
Sport (WADA)Not named on the 2026 Prohibited List; its section S0 bans any pharmacological substance with no current approval for human therapeutic use [7].
 Summaries of official sources, checked —. Rules change; follow the source links. Not legal advice.

We haven't published a full overview of Vilon yet. The legal status table and live prices on this page are current.

Vilon prices: cheapest listings

The five lowest $/mg listings out of 9. See all Vilon prices

Vendor Transparency Product Size Price $/mg vs median Stock Vendor's page
Modern Research Peptides 10/100* Vilon 20MG (22.04mg) 20 mg $43 $2.15/mg −21% In stock View
Orbitrex Peptides 73/100 Vilon 20mg 20 mg $50 $2.50/mg −8% — View
OROS Research 55/100* Vilon 20mg 20 mg $50 $2.50/mg −8% In stock View
Modern Aminos 77/100 VILON 20MG 20 mg $54 $2.70/mg −1% In stock View
Pure Lab Peptides 82/100 Vilon 20mg 20 mg $55 $2.75/mg +1% In stock View

Prices come from each vendor's public product feed and were last fetched Oct 15, 2026. They exclude shipping and discounts. $/mg uses the labeled amount, not measured content. A transparency score marked * is based on fewer than six checks; checks we couldn't complete score 0. How we compare prices.

Sources

  1. Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
  2. MHRA Products: licensed-medicine search for "vilon". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
  3. EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
  4. EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
  5. Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
  6. Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
  7. World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026
  8. KE peptide regulates SIRT1, PARP1, PARP2 gene expression and protein synthesis in human mesenchymal stem cells aging (in Russian). Advances in Gerontology (Uspekhi Gerontologii) (2023). Accessed Oct 15, 2026
  9. Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. International Journal of Molecular Sciences (2022). Accessed Oct 15, 2026